Design Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit 2022

Design Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit 2022

Design Therapeutics, Inc. CARLSBAD, Calif., Sept. Feb. 22, 2022 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, announced today that João Siffert, MD, President and CEO, and Sean Jeffries, Ph.D., Chief Operating Officer, will participate in a fireside chat during the Jefferies Cell and …

Design Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit 2022 Read More »